3 reports

Dr Graham Cooke, Chief Investigator of the STOP-HCV-## clinical trial, said: " We are pleased to incorporate the Genedrive IL##B point of care genotyping test in the STOP-HCV-## clinical trial which aims to identify key markers to guide the duration of

  • Lung Cancer
  • Prostate Cancer
  • United States
  • Company
  • AutoGenomics, Inc.

The trial included ## HCC patients who were enrolled into one of three treatment arms depending on whether or not they were infected with HCV or HBV.

  • Ear, Nose, And Throat Medicine
  • Hospital
  • Lung Cancer
  • Therapy
  • Company

One study passed its predefined statistical test in triple negative breast cancer.

  • Ear, Nose, And Throat Medicine
  • Hospital
  • Lung Cancer
  • Therapy
  • Company